Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因，你建议，在开始接受秋水仙碱治疗效果不明显转而接受苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明显转而接受氨砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因，你建议，在开始接受秋水仙碱治疗效果不明显转而接受苯砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不显转而接受砜治疗的患者应当继续服用秋水仙碱。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙碱治疗效果不明接受氨苯砜治疗的患者应当继续服用秋水仙碱。